What conditions have the most trials recruiting in Urasoe-shi, Japan?

In Urasoe-shi, Japan, the conditions with the most recruiting trials are Obesity (3), Obstructive Sleep Apnea (2), Atherosclerotic Cardiovascular Disease (1).

Clinical trials recruiting in Urasoe-shi, Japan

Recruiting trials

Conditions

Phase breakdown

Phase 3 3

Conditions recruiting in Urasoe-shi, Japan

Condition	Trials
Obesity	3
Obstructive Sleep Apnea	2
Atherosclerotic Cardiovascular Disease	1
Overweight	1

Recruiting trials in Urasoe-shi, Japan

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
NCT07226765 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
NCT07225686 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Urasoe-shi, Japan?

3 recruiting trials have at least one study site in Urasoe-shi, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.